Seres Therapeutics Inc. (MCRB)
NASDAQ: MCRB
· Real-Time Price · USD
16.70
-0.16 (-0.95%)
At close: Aug 15, 2025, 3:59 PM
16.08
-3.74%
After-hours: Aug 15, 2025, 07:58 PM EDT
Seres Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 64K | 310K | 126.47M | -522K | 975K | 3.44M | 1.22M | 1.49M | 7.22M | 126.72M | 5.26M | 5.72M |
Cost of Revenue | 1.06M | n/a | n/a | n/a | 1.42M | 1.56M | 4.05M | 519K | 2.11M | 3.61M | 1M | 43.12M | 43.94M | 976K | 36.75M | 1.13M | 35.95M | 29.3M |
Gross Profit | -1.06M | n/a | n/a | n/a | -1.42M | -1.56M | -3.99M | -209K | 124.37M | -4.13M | -29K | -39.67M | -42.72M | 517K | -29.53M | 125.6M | -30.69M | -23.59M |
Operating Income | -24.88M | -27.24M | -28.84M | -29.17M | -31.34M | -37.17M | -44.02M | -47.41M | 49.52M | -70.57M | -68.31M | -59.11M | -63.33M | -55.75M | -49.43M | 68.41M | -48.14M | -35.33M |
Interest Income | 546K | 618K | 437K | 652K | 1.23M | 1.65M | 1.97M | 2.57M | 1.73M | 1.03M | 1.41M | 865K | 395K | 384K | 485K | 590K | 829K | 966K |
Pretax Income | -19.86M | 32.68M | -15.64M | -51.03M | -32.87M | -40.13M | -41.25M | -47.85M | 46.55M | -71.17M | -68.8M | -60M | -64.73M | -56.62M | -50M | 68.22M | -48.33M | -35.47M |
Net Income | -19.86M | 32.68M | -15.64M | 88.78M | -32.87M | -40.13M | -41.25M | -47.85M | 46.55M | -71.78M | -69.28M | -60M | -64.73M | -57.5M | -50M | 68.22M | -48.33M | -35.47M |
Selling & General & Admin | 10.88M | 11.89M | 12.46M | 12.71M | 16.06M | 13.91M | 13.18M | 19.99M | 28.05M | 22.47M | 22.4M | 18.38M | 20.34M | 18.57M | 20.51M | 19.56M | 17.45M | 11.74M |
Research & Development | 12.94M | 11.82M | 12.84M | 16.46M | 17.88M | 21.7M | 26.85M | 28.25M | 46.79M | 43.97M | 46.22M | 43.12M | 43.94M | 39.65M | 36.75M | 39.88M | 35.95M | 29.3M |
Other Expenses | n/a | 3.53M | 3.53M | n/a | -2.59M | n/a | 336K | 999K | -1.51M | 3.61M | 658K | -33K | -304K | -976K | -316K | -35K | -285K | -409K |
Operating Expenses | 23.82M | 27.24M | 28.84M | 29.17M | 32.51M | 35.61M | 40.03M | 47.72M | 76.95M | 70.05M | 69.28M | 62.55M | 64.54M | 57.24M | 56.65M | 58.32M | 53.41M | 41.04M |
Interest Expense | n/a | n/a | n/a | n/a | 3.45M | 4.66M | 4.03M | 4.01M | 3.19M | 1.95M | 1.88M | 1.73M | 1.5M | 912K | 738K | 744K | 732K | 696K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -1.56M | -4.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 24.88M | n/a | 28.84M | 29.17M | 31.34M | 37.17M | 44.08M | 47.72M | 76.95M | 70.05M | 69.28M | 62.55M | 64.54M | 57.24M | 56.65M | 58.32M | 53.41M | 41.04M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -2.19M | n/a | 149K | 606K | 489K | n/a | n/a | 873K | n/a | n/a | 447K | 287K |
Shares Outstanding (Basic) | 8.74M | 8.7M | 7.7M | 7.63M | 7.58M | 146.1M | 6.46M | 128.29M | 127.71M | 125.86M | 108.08M | 122.53M | 92.26M | 92.16M | 91.7M | 91.76M | 91.66M | 91.53M |
Shares Outstanding (Diluted) | 8.74M | 8.71M | 7.7M | 7.63M | 7.58M | 146.1M | 6.46M | 128.29M | 129.84M | 125.86M | 108.08M | 122.53M | 92.26M | 92.16M | 91.7M | 94.95M | 91.66M | 91.53M |
EPS (Basic) | -2.27 | 3.76 | -0.1 | 11.60 | -0.22 | -0.27 | -0.32 | -0.37 | 0.36 | -0.57 | -0.55 | -0.49 | -0.7 | -0.62 | -0.54 | 0.74 | -0.53 | -0.39 |
EPS (Diluted) | -2.27 | 3.75 | -0.1 | 11.60 | -0.22 | -0.27 | -0.32 | -0.37 | 0.36 | -0.57 | -0.55 | -0.49 | -0.7 | -0.62 | -0.53 | 0.72 | -0.53 | -0.39 |
EBITDA | -18.8M | -27.24M | -12.54M | -49.63M | -28M | -33.91M | -33.17M | -39.95M | 53.44M | -65.76M | -63.62M | -57.36M | -61.55M | -54.14M | -46.73M | 71.28M | -45.36M | -32.64M |
EBIT | -19.86M | n/a | -15.64M | -51.03M | -29.42M | -35.47M | -37.22M | -43.84M | 49.74M | -69.23M | -66.92M | -58.27M | -63.23M | -55.71M | -49.26M | 68.96M | -47.6M | -34.77M |
Depreciation & Amortization | 1.06M | n/a | 3.09M | 1.4M | 1.42M | 1.56M | 4.05M | 3.89M | 3.7M | 3.47M | 3.29M | 1.75M | 2.93M | 2.63M | 2.54M | 2.32M | 2.24M | 2.13M |